Does Introducing Imprecision around Probabilities for Benefit and Harm Influence the Way People Value Treatments?

Medical Decision Making

Volumn 36, Issue 4, 2016, Pages 490-502

  Bansback, Nick ^a,b   Harrison, Mark ^b,c   Marra, Carlo ^d  

^a ST PAUL S HOSPITAL   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

discrete choice experiments; imprecision; treatment uncertainty

Indexed keywords

ADULT; ARTHRITIS, RHEUMATOID; CANADA; CLASSIFICATION; CLINICAL DECISION MAKING; CONTROLLED STUDY; DECISION MAKING; DECISION SUPPORT SYSTEM; DRUG ADMINISTRATION; DRUG ADMINISTRATION ROUTE; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HUMAN; LIFE EXPECTANCY; MALE; MIDDLE AGED; PATIENT PARTICIPATION; PATIENT PREFERENCE; PROBABILITY; PROCEDURES; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL;

ADULT; ARTHRITIS, RHEUMATOID; CANADA; CHOICE BEHAVIOR; CLINICAL DECISION-MAKING; DECISION SUPPORT TECHNIQUES; DRUG ADMINISTRATION ROUTES; DRUG ADMINISTRATION SCHEDULE; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HUMANS; LIFE EXPECTANCY; MALE; MIDDLE AGED; PATIENT PARTICIPATION; PATIENT PREFERENCE; PROBABILITY; SURVEYS AND QUESTIONNAIRES;

EID: 84964047183     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X15600708     Document Type: Conference Paper

References (43)

1. Stewart M,. Towards a global definition of patient centred care. BMJ. 2001; 322 (7284): 444-5.
2. Charles C, Gafni A, Whelan T,. Decision-making in the physician-patient encounter: revisiting the shared treatment decision-making model. Soc Sci Med. 1999; 49 (5): 651-61.
3. Sepucha KR, Borkhoff CM, Lally J, et al. Establishing the effectiveness of patient decision aids: key constructs and measurement instruments. BMC Med Inform Decis Mak. 2013; 13 (Suppl 2): S12.
4. O'Connor AM,. Using decision aids to help patients navigate the "grey zone" of medical decision-making. CMAJ. 2007; 176 (11): 1597-8.
5. Gafni A, Charles C, Whelan T,. The physician-patient encounter: the physician as a perfect agent for the patient versus the informed treatment decision-making model. Soc Sci Med. 1998; 47 (3): 347-54.
6. Politi MC, Han PKJ, Col NF,. Communicating the uncertainty of harms and benefits of medical interventions. Med Decis Making. 2007; 27 (5): 681-95.
7. Feldman-Stewart D, O'Brien MA, Clayman ML, et al. Providing information about options in patient decision aids. BMC Med Inform Decis Mak. 2013; 13 (Suppl 2): S4.
8. Han PKJ, Klein WMP, Lehman T, Killam B, Massett H, Freedman AN,. The communication of uncertainty regarding individualized cancer risk estimates: effects and influential factors. Med Decis Mak. 2011; 31 (2): 354-66.
9. Longman T, Turner RM, King M, McCaffery KJ,. The effects of communicating uncertainty in quantitative health risk estimates. Patient Educ Couns. 2012; 89 (2): 252-9.
10. Brewer NT, Richman AR, DeFrank JT, Reyna VF, Carey LA,. Improving communication of breast cancer recurrence risk. Breast Cancer Res Treat. 2012; 133 (2): 553-61.
11. McCormack L, Sheridan S, Lewis M, et al. Communication and Dissemination Strategies to Facilitate the Use of Health-Related Evidence. Rockville (MD): Agency for Healthcare Research and Quality; 2013.
12. Lipkus IM, Klein WM, Rimer BK,. Communicating breast cancer risks to women using different formats. Cancer Epidemiol Biomark Prev. 2001; 10 (8): 895-8.
13. Ellsberg D,. Risk, ambiguity, and the Savage axioms. Q J Econ. 1961; 643-69.
14. Viscusi WK, Magat WA, Huber J,. Communication of ambiguous risk information. Theory Decis. 1991; 31 (2-3): 159-73.
15. Louviere JJ, Woodworth G,. Design and analysis of simulated consumer choice or allocation experiments: an approach based on aggregate data. J Mark Res. 1983; 20 (4): 350-67.
16. Louviere JJ, Hensher DA, Swait JD,. Stated Choice Methods: Analysis and Applications. Cambridge (UK): Cambridge University Press; 2000.
17. Wood AJ, Olsen NJ, Stein CM,. New drugs for rheumatoid arthritis. N Engl J Med. 2004; 350 (21): 2167-79.
18. Singh JA, Christensen R, Wells GA, et al. Biologics for rheumatoid arthritis: an overview of Cochrane reviews. Cochrane Database Syst Rev. 2009;(4): CD007848.
19. Zhang J, Xie F, Delzell E, et al. Trends in the use of biologic agents among rheumatoid arthritis patients enrolled in the US Medicare program. Arthritis Care Res. 2013; 65 (11): 1743-51.
20. Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V,. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA. 2006; 295 (19): 2275-85.
21. Lopez-Olivo M, Tayar J, Martinez-Lopez J, et al. Risk of malignancies in patients with rheumatoid arthritis treated with biologic therapy: a meta-analysis. JAMA. 2012; 308 (9): 898-908.
22. Singh JA,. Use of biologics in a patient with rheumatoid arthritis refractory to methotrexate. Can Med Assoc J. 2013; 185 (9): 793-5.
23. Schildmann J, Grunke M, Kalden JR, Vollmann J,. Information and participation in decision-making about treatment: a qualitative study of the perceptions and preferences of patients with rheumatoid arthritis. J Med Ethics. 2008; 34 (11): 775-9.
24. Bansback N, Brazier J, Tsuchiya A, Anis A,. Using a discrete choice experiment to estimate health state utility values. J Health Econ. 2011; 31 (1): 306-18.
25. Ottawa Hospital Research Institute. Decision Aid Library Inventory (DALI). Patient decision aids. Available from: URL: http://decisionaid.ohri.ca/cochinvent.php
26. Brust-Renck PG, Royer CE, Reyna VF,. Communicating numerical risk human factors that aid understanding in health care. Rev Hum Factors Ergon. 2013; 8 (1): 235-76.
27. Spiegelhalter D, Pearson M, Short I,. Visualizing uncertainty about the future. Science. 2011; 333 (6048): 1393-400.
28. Balshem H, Helfand M, Schünemann HJ, et al. GRADE guidelines, 3: rating the quality of evidence. J Clin Epidemiol. 2011; 64 (4): 401-6.
29. Fagerlin A, Zikmund-Fisher BJ, Ubel PA, Jankovic A, Derry HA, Smith DM,. Measuring numeracy without a math test: development of the subjective numeracy scale. Med Decis Making. 2007; 27 (5): 672-80.
30. O'Connor AM,. User manual-decisional conflict scale. 2010. Available from: URL: https://decisionaid.ohri.ca/docs/develop/User-Manuals/UM-Decisional-Conflict.pdf
31. Dolan JG, Qian F, Veazie PJ,. How well do commonly used data presentation formats support comparative effectiveness evaluations? Med Decis Making. 2012; 32 (6): 840-50.
32. Scott A,. Identifying and analysing dominant preferences in discrete choice experiments: an application in health care. J Econ Psychol. 2002; 23 (3): 383-98.
33. DeShazo JR, Fermo G,. Designing choice sets for stated preference methods: the effects of complexity on choice consistency. J Environ Econ Manag. 2002; 44 (1): 123-43.
34. Revelt D, Train K,. Customer-Specific Taste Parameters and Mixed Logit: Households' Choice of Electricity Supplier. No. E00-274. Berkeley (CA): University of California at Berkeley; 2000.
35. Muscatello DJ, Searles A, MacDonald R, Jorm L,. Communicating population health statistics through graphs: a randomised controlled trial of graph design interventions. BMC Med. 2006; 4: 33.
36. Reyna VF,. A theory of medical decision making and health: fuzzy trace theory. Med Decis Making 2008; 28 (6): 850-65.
37. Dieckmann NF, Mauro R, Slovic P,. The effects of presenting imprecise probabilities in intelligence forecasts: effects of presenting imprecise probabilities in intelligence forecasts. Risk Anal. 2010; 30 (6): 987-1001.
38. Harrison M, Rigby D, Vass C, Flynn T, Louviere J, Payne K,. Risk as an attribute in discrete choice experiments: a systematic review of the literature. Patient. 2014; 7 (2): 151-70.
39. Han PK, Klein WM, Lehman TC, Massett H, Lee SC, Freedman AN,. Laypersons' responses to the communication of uncertainty regarding cancer risk estimates. Med Decis Making. 2009; 29 (3): 391-403.
40. Schapira MM, Nattinger AB, McHorney CA,. Frequency or probability? A qualitative study of risk communication formats used in health care. Med Decis Making. 2001; 21 (6): 459-67.
41. Politi MC, Lewis CL, Frosch DL,. Supporting shared decisions when clinical evidence is low. Med Care Res Rev. 2013; 70 (1 Suppl): 113S-128S.
42. De Bekker-Grob EW, Ryan M, Gerard K,. Discrete choice experiments in health economics: a review of the literature. Health Econ. 2012; 21 (2): 145-72.
43. Mark T, Swait J,. Using Stated Preference and Revealed Preference Data Fusion Modelling in Health Care. Using Discrete Choice Experiments to Value Health and Health Care. New York: Springer; 2008.